Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.
Cheung NK, Cheung IY, Kushner BH, Ostrovnaya I, Chamberlain E, Kramer K, Modak S. Cheung NK, et al. Among authors: ostrovnaya i. J Clin Oncol. 2012 Sep 10;30(26):3264-70. doi: 10.1200/JCO.2011.41.3807. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869886 Free PMC article. Clinical Trial.
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.
Cheung NK, Cheung IY, Kramer K, Modak S, Kuk D, Pandit-Taskar N, Chamberlain E, Ostrovnaya I, Kushner BH. Cheung NK, et al. Among authors: ostrovnaya i. Int J Cancer. 2014 Nov 1;135(9):2199-205. doi: 10.1002/ijc.28851. Epub 2014 Apr 3. Int J Cancer. 2014. PMID: 24644014 Free PMC article. Clinical Trial.
Osteochondroma in long-term survivors of high-risk neuroblastoma.
Kushner BH, Roberts SS, Friedman DN, Kuk D, Ostrovnaya I, Modak S, Kramer K, Basu EM, Cheung NK. Kushner BH, et al. Among authors: ostrovnaya i. Cancer. 2015 Jun 15;121(12):2090-6. doi: 10.1002/cncr.29316. Epub 2015 Feb 27. Cancer. 2015. PMID: 25728463 Free PMC article.
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.
Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Kramer K, Modak S, Yataghene K, Cheung NK. Kushner BH, et al. Among authors: ostrovnaya i. Oncoimmunology. 2015 May 22;4(7):e1016704. doi: 10.1080/2162402X.2015.1016704. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140243 Free PMC article.
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM, Ali SM, Miller VA, Mossé YP, Granger MP, Weiss B, Maris JM, Modak S. Padovan-Merhar OM, et al. Among authors: ostrovnaya i. PLoS Genet. 2016 Dec 20;12(12):e1006501. doi: 10.1371/journal.pgen.1006501. eCollection 2016 Dec. PLoS Genet. 2016. PMID: 27997549 Free PMC article.
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.
Modak S, Le Luduec JB, Cheung IY, Goldman DA, Ostrovnaya I, Doubrovina E, Basu E, Kushner BH, Kramer K, Roberts SS, O'Reilly RJ, Cheung NV, Hsu KC. Modak S, et al. Among authors: ostrovnaya i. Oncoimmunology. 2018 May 10;7(8):e1461305. doi: 10.1080/2162402X.2018.1461305. eCollection 2018. Oncoimmunology. 2018. PMID: 30221057 Free PMC article.
128 results